A year-to-date look at the federal and state measures shaping supplement oversight, access, and classification.

A panel at The Outlook on Active Nutrition discussed quality in sports nutrition focused on testing, liability, and what buyers now expect from suppliers.

This Q&A with Maypro's Lauren Clardy discusses the innovation areas—from scientific substantiation to delivery systems—set to define the future of skin and hair health.

Trade groups say the law's broad criteria could restrict access to supplements with uses beyond weight loss or muscle building.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.